Pages
Accessible information standards
https://dchs.nhs.uk/about-us/equality-diversity-inclusion/accessible-information
Interpreting & translation
https://dchs.nhs.uk/about-us/equality-diversity-inclusion/interpreting-translation
Patient Safety
Patient Safety is the freedom from harm in healthcare and is a process by which an organisation makes patient care safer.
https://dchs.nhs.uk/about-us/quality-heart-our-care/patient-safety
Diabetes Education Service
If you have type 2 diabetes, attending an education programme is an important part of your treatment plan.
Research and Innovation
Our vision is to increase capacity, capability and participation in research and innovation as we embed a culture of continuous improvement across the organisation.
Community podiatry - Our Services
Community podiatry services - what services are offered by DCHS community podiatry team
Files
GD23 Recruitment and Selection Information Guidance for Applicants.docx
Disclosure Ref 202511 - Facilities Management.pdf
Disclosure to freedom of information request regarding soft facilities management service provider
Requesting GP Prescribing SOP (S147)
To enable non-prescribing clinicians access to an internal group of DCHS prescribers to ensure patients receive clinically indicated medicines in a timely way without putting undue pressure on Community GPs within the system.
Sending information via email.docx
HRP20 Supporting and Maintaining Attendance Policy
v2 November 2025
Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)
The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.
L145 - Important advice for casts on lower limbs
Important advice for casts on lower limbs, patient information leaflet.
CoG - 11 March 2020 - updated.pdf
CoG Meeting Pack March 2020
Advance Decisions Policy
It is a general principle of law and medical practice that adults have a right to consent to or refuse treatment. The courts have recognised that adults have the right to say in advance that they want to refuse treatment if they lose capacity in the future, even if this results in their death. A valid and applicable advance decision to refuse treatment has the same force as a contemporaneous decision. This has been a fundamental principle of the common law for many years and is now set out in the Mental Capacity Act 2005, which came into force in 2007 supported by the Code of Practice to the Act. Derbyshire Community Health Services NHS Foundation Trust aims to achieve a more balanced partnership between patients and healthcare professionals and acknowledges that it is the right of every adult patient with capacity to determine whether or not to accept medical treatment. In addition, it is the right of every adult patient to express views about their future care and treatment. The primary responsibility lies with the patient (the maker) to write an Advance Decision to Refuse Treatment (ADRT). The Trust endorses the good practice of staff, set out in national guidance and professional standards to provide information to and general support for patients who wish to write an ADRT. The Trust always encourages patients who wish to discuss their plans for future care and will provide advice to patients and support to advance care planning by helping to coordinate care and communicate plans. In addition, it is supportive of those patients who present with an advance decision and where this is valid and applicable, comply with that specific decision. This policy should be read in conjunction with the Trust’s Consent Policy and aims to raise awareness and give guidance to staff about advance decisions.
Midazolam by Buccal Administration for Children (UTC)
PGD Midazolam by Buccal Administration for Children (UTC)